- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zoetis Inc (ZTS)
Zoetis Inc stock price live, this page displays NYSE ZTS stock exchange data. View the ZTS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zoetis Inc real time stock price chart below.
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 76.09.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 76.09.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.55
77.61
52 wk Range
72.38
161.77
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.5577.61
52 wk Range
72.38161.77
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZTS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
124.59
Upside
+63.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 13 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
11 Buy
9 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 124.59
(+63.74% Upside)
Zoetis Inc SWOT Analysis
Market Leadership | Zoetis maintains dominance in animal health, with a robust portfolio spanning companion animal and livestock sectors, despite increasing competition |
Financial Resilience | Analysts project continued growth, with Q3 2024 organic revenue expected to rise 9.2%. Price targets range from $225 to $242, reflecting positive outlook |
Product Innovation | Explore Zoetis's key growth drivers, including Librela for canine osteoarthritis and Apoquel for dermatology, alongside a promising pipeline in oncology and cardiology |
Future Prospects | Delve into Zoetis's strategies for tapping untapped markets in animal anti-depressants and pain management, while navigating challenges like foreign exchange impacts |
Zoetis Inc Earnings Call Summary for Q1/2026
- Zoetis Q1 2026 revenue met forecasts at $2.3B, but EPS of $1.53 missed estimates of $1.62, a 5.56% shortfall impacting investor confidence.
- Stock plummeted 25.53% post-earnings to $82.83, continuing decline to $74.39, near 52-week low amid profitability concerns and market pressures.
- U.S. companion animal segment declined significantly; international livestock showed resilience with adjusted gross margins at 71.8%, down 10 bps.
- CEO Kristin Peck cited macroeconomic headwinds and competitive pressures, emphasizing commitment to pipeline innovation and strategic growth initiatives.
- FY2026 revenue guidance set at $9.86B; Q3/Q4 EPS forecasts at $1.88/$1.85 respectively; Cytopoint Plus launch planned by end of 2027.
Last Updated: 2026-05-13, 03:38 p/m
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
1.53 / 1.62
Revenue / Forecast
2.3B / 2.3B
Compare ZTS to Peers and Sector
Metrics to compare | ZTS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZTSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.9x | 14.8x | −0.4x | |
PEG Ratio | 1.08 | 0.19 | 0.00 | |
Price/Book | 9.9x | 2.3x | 2.6x | |
Price / LTM Sales | 3.3x | 2.5x | 3.0x | |
Upside (Analyst Target) | 71.0% | 13.5% | 56.9% | |
Fair Value Upside | Unlock | −1.1% | 9.3% | Unlock |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Zoetis Inc (ZTS) Stock Price Today?
The Zoetis Inc stock price today is 76.09 USD.
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
Does Zoetis Inc Pay Dividends? What’s The Current Dividend Yield?
The Zoetis Inc dividend yield is 2.72%.
What Is the Zoetis Inc Market Cap?
As of today, Zoetis Inc market cap is 31.93B USD.
What Is Zoetis Inc's Earnings Per Share (TTM)?
The Zoetis Inc EPS (TTM) is 6.11.
When Is the Next Zoetis Inc Earnings Date?
Zoetis Inc will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is ZTS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Zoetis Inc Stock Split?
Zoetis Inc has split 0 times.
How Many Employees Does Zoetis Inc Have?
Zoetis Inc has 14500 employees.
What is the current trading status of Zoetis Inc (ZTS)?
As of Jun 27, 2026, Zoetis Inc (ZTS) is trading at a price of 76.09 USD, with a previous close of 77.82 USD. The stock has fluctuated within a day range of 75.55 USD to 77.61 USD, while its 52-week range spans from 72.38 USD to 161.77 USD.
What Is Zoetis Inc (ZTS) Price Target According to Analysts?
The average 12-month price target for Zoetis Inc is 124.59 USD, with a high estimate of 160 USD and a low estimate of 90 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +63.74% Upside potential.
What Is the ZTS Premarket Price?
ZTS's last pre-market stock price is 75.69 USD. The pre-market share volume is 27,940.00, and the stock has decreased by -2.13, or -2.74%.
What Is the ZTS After Hours Price?
ZTS's last after hours stock price is 76.50 USD, the stock has decreased by 0.41, or 0.54%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.